The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels

Background. We used a random sample (n = 2, 495) from the population-based Prevention of Renal and Vascular End-stage Disease (PREVEND) study population to examine the association of the metabolic syndrome (Met S) with plasminogen activator inhibitor type 1 (PAI-1) and tissue plasminogen activator (...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffey, Christopher S., Asselbergs, Folkert W., Hebert, Patricia R., Hillege, Hans L., Li, Qing, Moore, Jason H., van Gilst, Wiek H.
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087975/
https://www.ncbi.nlm.nih.gov/pubmed/21559217
http://dx.doi.org/10.4061/2011/541467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087975/
https://www.ncbi.nlm.nih.gov/pubmed/21559217
http://dx.doi.org/10.4061/2011/541467

Ejemplares similares